These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1037 related items for PubMed ID: 24655528

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL.
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Denosumab and osteonecrosis of the jaws - the pharmacology, pathogenesis and a report of two cases.
    O'Halloran M, Boyd NM, Smith A.
    Aust Dent J; 2014 Dec; 59(4):516-9. PubMed ID: 25131835
    [Abstract] [Full Text] [Related]

  • 7. Review of current literature and implications of RANKL inhibitors for oral health care providers.
    Epstein MS, Ephros HD, Epstein JB.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Dec; 116(6):e437-42. PubMed ID: 22901640
    [Abstract] [Full Text] [Related]

  • 8. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB.
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease.
    Sivolella S, Lumachi F, Stellini E, Favero L.
    Anticancer Res; 2013 May; 33(5):1793-7. PubMed ID: 23645723
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Osteonecrosis of the jaw.
    Drozdzowska B.
    Endokrynol Pol; 2011 May; 62(1):88-92. PubMed ID: 21365586
    [Abstract] [Full Text] [Related]

  • 14. Infection and medication-related osteonecrosis of the jaw.
    Katsarelis H, Shah NP, Dhariwal DK, Pazianas M.
    J Dent Res; 2015 Apr; 94(4):534-9. PubMed ID: 25710950
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A current update on osteonecrosis of the jaw and bisphosphonates.
    Arrain Y, Masud T.
    Dent Update; 2011 Dec; 38(10):672-6, 678. PubMed ID: 22408887
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK.
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [Abstract] [Full Text] [Related]

  • 19. Osteonecrosis of the jaw and the role of macrophages.
    Pazianas M.
    J Natl Cancer Inst; 2011 Feb 02; 103(3):232-40. PubMed ID: 21189409
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.